Soluble NKG2D ligands limit the efficacy of immune checkpoint blockade
Publication date:
2017
Publisher version:
Citación:
Oncoimmunology, 6(10), (2017); doi:10.1080/2162402X.2017.1346766
ISSN:
Patrocinado por:
ALS and SG are supported by Spanish Instituto de Salud Carlos III (FIS PI16/01485). LG is supported by an intramural startup from the Department of Radiation Oncology of Weill Cornell Medical College (New York, US), and by Sotio a.c. (Prague, Czech Republic).
Collections
- Artículos [36274]
Files in this item
Métricas
Compartir
